Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 106 articles:
HTML format
Text format



Single Articles


    January 2019
  1. CHENG X, Jin Z, Ji X, Shen X, et al
    ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB.
    Int J Cancer. 2019 Jan 16. doi: 10.1002/ijc.32071.
    PubMed     Text format     Abstract available


  2. DEVAUD C, Tilkin-Mariame AF, Vignolle-Vidoni A, Souleres P, et al
    FAK alternative splice mRNA variants expression pattern in colorectal cancer.
    Int J Cancer. 2019 Jan 10. doi: 10.1002/ijc.32120.
    PubMed     Text format     Abstract available


  3. WONG R, Tie J, Lee M, Cohen J, et al
    The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with non-specific findings on standard investigations.
    Int J Cancer. 2019 Jan 10. doi: 10.1002/ijc.32117.
    PubMed     Text format     Abstract available


  4. YAN C, Huang WY, Boudreau J, Mayavannan A, et al
    IL-17R deletion predicts high-grade colorectal cancer and poor clinical outcomes.
    Int J Cancer. 2019 Jan 10. doi: 10.1002/ijc.32122.
    PubMed     Text format     Abstract available


  5. SONG M, Ou FS, Zemla TJ, Hull MA, et al
    Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance).
    Int J Cancer. 2019 Jan 8. doi: 10.1002/ijc.32113.
    PubMed     Text format     Abstract available


  6. JORISSEN RN, Croxford M, Jones IT, Ward RL, et al
    Evaluation of the Transferability of Survival Calculators for Stage II/III Colon Cancer Across Healthcare Systems.
    Int J Cancer. 2019 Jan 8. doi: 10.1002/ijc.32100.
    PubMed     Text format     Abstract available


  7. MODEST DP, Rivera F, Bachet JB, de Braud F, et al
    Panitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: a retrospective analysis of two randomised trials.
    Int J Cancer. 2019 Jan 7. doi: 10.1002/ijc.32110.
    PubMed     Text format     Abstract available


  8. MYTE R, Gylling B, Haggstrom J, Haggstrom C, et al
    Metabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation status.
    Int J Cancer. 2019 Jan 7. doi: 10.1002/ijc.32104.
    PubMed     Text format     Abstract available


  9. HU J, Shan Y, Ma J, Pan Y, et al
    LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating alpha-2, 3 sialylation via PI3K/Akt signaling.
    Int J Cancer. 2019 Jan 7. doi: 10.1002/ijc.32103.
    PubMed     Text format     Abstract available


    December 2018
  10. WARD HA, Murphy N, Weiderpass E, Leitzmann MF, et al
    Gallstones and incident colorectal cancer in a large pan-European cohort study.
    Int J Cancer. 2018 Dec 26. doi: 10.1002/ijc.32090.
    PubMed     Text format     Abstract available


  11. VICENTINI M, Zorzi M, Bovo E, Mancuso P, et al
    Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer. Results from the IMPATTO study.
    Int J Cancer. 2018 Dec 26. doi: 10.1002/ijc.32089.
    PubMed     Text format     Abstract available


  12. REN A, Sun S, Li S, Chen T, et al
    Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer.
    Int J Cancer. 2018 Dec 18. doi: 10.1002/ijc.32079.
    PubMed     Text format     Abstract available


  13. ZAIMENKO I, Jaeger C, Brenner H, Chang-Claude J, et al
    Non-invasive metastasis prognosis from plasma metabolites in stage II colorectal cancer patients: the DACHS study.
    Int J Cancer. 2018 Dec 18. doi: 10.1002/ijc.32076.
    PubMed     Text format     Abstract available


  14. YANG T, Li X, Montazeri Z, Little J, et al
    Gene-environment interactions and colorectal cancer risk: an umbrella review of systematic reviews and meta-analyses of observational studies.
    Int J Cancer. 2018 Dec 11. doi: 10.1002/ijc.32057.
    PubMed     Text format     Abstract available


  15. ARAGHI M, Soerjomataram I, Jenkins M, Brierley J, et al
    Global trends in colorectal cancer mortality: projections to the year 2035.
    Int J Cancer. 2018 Dec 10. doi: 10.1002/ijc.32055.
    PubMed     Text format     Abstract available


  16. ROSEWEIR AK, Clark J, McSorley ST, van Wyk HC, et al
    The association between markers of tumor cell metabolism, the tumor microenvironment and outcomes in patients with colorectal cancer.
    Int J Cancer. 2018 Dec 6. doi: 10.1002/ijc.32045.
    PubMed     Text format     Abstract available


  17. PETIMAR J, Tabung FK, Valeri L, Rosner B, et al
    Mediation of Associations Between Adiposity and Colorectal Cancer Risk by Inflammatory and Metabolic Biomarkers.
    Int J Cancer. 2018 Dec 6. doi: 10.1002/ijc.32047.
    PubMed     Text format     Abstract available


  18. JIANG W, Cai M, Li S, Bei J, et al
    Universal screening for Lynch Syndrome in a large consecutive cohort of Chinese colorectal cancer patients: high prevalence and unique molecular features.
    Int J Cancer. 2018 Dec 6. doi: 10.1002/ijc.32044.
    PubMed     Text format     Abstract available


  19. IBRAHIM A, Hugerth L, Hases L, Saxena A, et al
    Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity.
    Int J Cancer. 2018 Dec 4. doi: 10.1002/ijc.32037.
    PubMed     Text format     Abstract available


    November 2018
  20. DAI Z, Zhang J, Wu Q, Chen J, et al
    The role of microbiota in the development of colorectal cancer.
    Int J Cancer. 2018 Nov 26. doi: 10.1002/ijc.32017.
    PubMed     Text format     Abstract available


  21. EIDE PW, Eilertsen IA, Sveen A, Lothe RA, et al
    Long non-coding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell-intrinsic properties.
    Int J Cancer. 2018 Nov 17. doi: 10.1002/ijc.31998.
    PubMed     Text format     Abstract available


  22. WANG G, Wang Q, Huang Q, Chen Y, et al
    Upregulation of mtSSB by interleukin-6 promotes cell growth through mitochondrial biogenesis-mediated telomerase activation in colorectal cancer.
    Int J Cancer. 2018 Nov 10. doi: 10.1002/ijc.31978.
    PubMed     Text format     Abstract available


  23. FU X, Huang Y, Fan X, Deng Y, et al
    Demographic Trends and KRAS/BRAF(V600E) Mutations in Colorectal Cancer Patients of South China: a Single-site Report.
    Int J Cancer. 2018 Nov 10. doi: 10.1002/ijc.31973.
    PubMed     Text format     Abstract available


  24. AMITAY EL, Cuk K, Niedermaier T, Weigl K, et al
    Factors Associated with False Positive Fecal Immunochemical Tests in a Large German Colorectal Cancer Screening Study.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31972.
    PubMed     Text format     Abstract available


  25. SUENAGA M, Cao S, Zhang W, Yang D, et al
    Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31968.
    PubMed     Text format     Abstract available


    October 2018
  26. FUJI T, Umeda Y, Nyuya A, Taniguchi F, et al
    Detection of Circulating MicroRNAs with Ago2 Complexes to Monitor the Tumor Dynamics of Colorectal Cancer Patients during Chemotherapy.
    Int J Cancer. 2018 Oct 31. doi: 10.1002/ijc.31960.
    PubMed     Text format     Abstract available


  27. YANG Y, Cai Q, Shu XO, Steinwandel MD, et al
    Prospective Study of Oral Microbiome and Colorectal Cancer Risk in Low-income and African American Populations.
    Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31941.
    PubMed     Text format     Abstract available


  28. VACCARO CA, Lopez-Kostner F, Valle AD, Palmero EI, et al
    From colorectal cancer pattern to the characterization of individuals at risk: picture for genetic research in Latin America.
    Int J Cancer. 2018 Oct 10. doi: 10.1002/ijc.31920.
    PubMed     Text format     Abstract available


  29. RATJEN I, Shivappa N, Schafmayer C, Burmeister G, et al
    Association between the dietary inflammatory index and all-cause mortality in colorectal cancer long-term survivors.
    Int J Cancer. 2018 Oct 10. doi: 10.1002/ijc.31919.
    PubMed     Text format     Abstract available


    September 2018
  30. BORMANN F, Stinzing S, Tierling S, Morkel M, et al
    Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancer.
    Int J Cancer. 2018 Sep 25. doi: 10.1002/ijc.31892.
    PubMed     Text format     Abstract available


  31. GARGALLO CJ, Lanas A, Carrera-Lasfuentes P, Ferrandez A, et al
    Genetic susceptibility in the development of colorectal adenomas according to family history of colorectal cancer.
    Int J Cancer. 2018 Sep 8. doi: 10.1002/ijc.31858.
    PubMed     Text format     Abstract available


  32. KLEIN CH, Truxius DC, Vogel HA, Harizanova J, et al
    PDEdelta inhibition impedes the proliferation and survival of human colorectal cancer cell lines harboring oncogenic KRas.
    Int J Cancer. 2018 Sep 8. doi: 10.1002/ijc.31859.
    PubMed     Text format     Abstract available


    August 2018
  33. PRASETYANTI PR, van Hooff SR, van Herwaarden T, de Vries N, et al
    Capturing Colorectal Cancer Inter-Tumor Heterogeneity in Patient-Derived Xenograft (PDX) Models.
    Int J Cancer. 2018 Aug 27. doi: 10.1002/ijc.31767.
    PubMed     Text format     Abstract available


  34. SONG M, Sasazuki S, Camargo MC, Shimazu T, et al
    Circulating Inflammatory Markers and Colorectal Cancer Risk: A Prospective Case-cohort Study in Japan.
    Int J Cancer. 2018 Aug 21. doi: 10.1002/ijc.31821.
    PubMed     Text format     Abstract available


  35. EILERTSEN IA, Sveen A, Stromme JM, Skotheim RI, et al
    Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer.
    Int J Cancer. 2018 Aug 19. doi: 10.1002/ijc.31809.
    PubMed     Text format     Abstract available


  36. BROUWER NPM, Bos ACRK, Lemmens VEPP, Tanis PJ, et al
    An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients.
    Int J Cancer. 2018 Aug 10. doi: 10.1002/ijc.31785.
    PubMed     Text format     Abstract available


  37. CAI M, Zhang H, Hou L, Gao W, et al
    Inhibiting homologous recombination decreases extrachromosomal amplification but has no effect on intrachromosomal amplification in methotrexate-resistant colon cancer cells.
    Int J Cancer. 2018 Aug 2. doi: 10.1002/ijc.31781.
    PubMed     Text format     Abstract available


  38. KWOK ZH, Roche V, Chew XH, Fadieieva A, et al
    A non-canonical tumor suppressive role for the long non-coding RNA MALAT1 in colon and breast cancers.
    Int J Cancer. 2018;143:668-678.
    PubMed     Text format     Abstract available


    July 2018
  39. ROSEWEIR AK, Kong CY, Park JH, Bennett L, et al
    A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with stage II/III colorectal cancer.
    Int J Cancer. 2018 Jul 11. doi: 10.1002/ijc.31739.
    PubMed     Text format     Abstract available


  40. YUAN Y, Qi G, Shen H, Guo A, et al
    Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer.
    Int J Cancer. 2018 Jul 10. doi: 10.1002/ijc.31736.
    PubMed     Text format     Abstract available


  41. CHEN C, Stock C, Hoffmeister M, Brenner H, et al
    How long does it take until the effects of endoscopic screening on colorectal cancer mortality are fully disclosed? : A Markov model study.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31716.
    PubMed     Text format     Abstract available


  42. PARK YL, Kim HP, Cho YW, Min DW, et al
    Activation of WNT/beta-catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31662.
    PubMed     Text format     Abstract available


  43. PAPANTONIOU K, Devore EE, Massa J, Strohmaier S, et al
    Rotating Night Shift work and Colorectal Cancer Risk in the Nurses' Health Studies.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31655.
    PubMed     Text format     Abstract available


  44. AHADOVA A, Gallon R, Gebert J, Ballhausen A, et al
    Three molecular pathways model colorectal carcinogenesis in Lynch syndrome.
    Int J Cancer. 2018;143:139-150.
    PubMed     Text format     Abstract available


    June 2018
  45. BOYSEN AK, Spindler KL, Hoyer M, Mortensen FV, et al
    Metastasis directed therapy for liver and lung metastases from colorectal cancer - a population based study.
    Int J Cancer. 2018 Jun 19. doi: 10.1002/ijc.31626.
    PubMed     Text format     Abstract available


  46. DASHTI SG, Win AK, Hardikar SS, Glombicki SE, et al
    Physical activity and the risk of colorectal cancer in Lynch syndrome.
    Int J Cancer. 2018 Jun 14. doi: 10.1002/ijc.31611.
    PubMed     Text format     Abstract available


  47. MAO Y, Feng Q, Zheng P, Yang L, et al
    Low Tumor Infiltrating Mast Cell Density Confers Prognostic Benefit and Reflects Immunoactivation in Colorectal Cancer.
    Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31613.
    PubMed     Text format     Abstract available


  48. FORMICA V, Zaniboni A, Loupakis F, Roselli M, et al
    Non-inferiority of three months vs six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice?
    Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31616.
    PubMed     Text format     Abstract available


    May 2018
  49. GYLLING B, Myte R, Ulvik A, Ueland PM, et al
    One-carbon metabolite ratios as functional B-vitamin markers and in relation to colorectal cancer risk.
    Int J Cancer. 2018 May 22. doi: 10.1002/ijc.31606.
    PubMed     Text format     Abstract available


  50. HUANG X, Yang Y, Zhao Y, Cao D, et al
    RhoA-stimulated intra-capillary morphology switch facilitates the arrest of individual circulating tumor cells.
    Int J Cancer. 2018;142:2094-2105.
    PubMed     Text format     Abstract available


  51. TAYLOR ES, McCall JL, Shen S, Girardin A, et al
    Prognostic roles for IL-2-producing and CD69(+) T cell subsets in colorectal cancer patients.
    Int J Cancer. 2018 May 11. doi: 10.1002/ijc.31598.
    PubMed     Text format     Abstract available


    April 2018
  52. MURPHY N, Achaintre D, Zamora-Ros R, Jenab M, et al
    A Prospective Evaluation of Plasma Polyphenol Levels and Colon Cancer Risk.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31563.
    PubMed     Text format     Abstract available


  53. CHEN L, Pan X, Hu X, Zhang YH, et al
    Gene expression differences among different MSI statuses in colorectal cancer.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31554.
    PubMed     Text format     Abstract available


  54. BARRUBES L, Babio N, Mena-Sanchez G, Toledo E, et al
    Dairy product consumption and risk of colorectal cancer in an older Mediterranean population at high cardiovascular risk.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31540.
    PubMed     Text format     Abstract available


  55. TRIFF K, McLean MW, Callaway E, Goldsby J, et al
    Dietary fat and fiber interact to uniquely modify global histone post-translational epigenetic programming in a rat colon cancer progression model.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31525.
    PubMed     Text format     Abstract available


  56. WU JC, Tsai ML, Lai CS, Lo CY, et al
    Polymethoxyflavones prevent benzo[a]pyrene/dextran sodium sulfate-induced colorectal carcinogenesis through modulating xenobiotic metabolism and ameliorate autophagic defect in ICR mice.
    Int J Cancer. 2018;142:1689-1701.
    PubMed     Text format     Abstract available


  57. LIU X, Zhou W, Zhang X, Ding Y, et al
    1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells.
    Int J Cancer. 2018 Apr 1. doi: 10.1002/ijc.31417.
    PubMed     Text format     Abstract available


  58. TABATABAEI M, Mosaffa N, Ghods R, Nikoo S, et al
    Vaccination with human amniotic epithelial cells confer effective protection in a murine model of Colon adenocarcinoma.
    Int J Cancer. 2018;142:1453-1466.
    PubMed     Text format     Abstract available


    March 2018
  59. LI X, Guo X, Li D, Du X, et al
    Multi-regional Sequencing Reveals Intratumor Heterogeneity and Positive Selection of Somatic mtDNA Mutations in Hepatocellular Carcinoma and Colorectal Cancer.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31395.
    PubMed     Text format     Abstract available


  60. FADDA A, Gentilini D, Moi L, Barault L, et al
    Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor.
    Int J Cancer. 2018 Mar 15. doi: 10.1002/ijc.31380.
    PubMed     Text format     Abstract available


  61. ZHOU M, Liu X, Li Z, Huang Q, et al
    Caspase-3 regulates the migration, invasion, and metastasis of colon cancer cells.
    Int J Cancer. 2018 Mar 10. doi: 10.1002/ijc.31374.
    PubMed     Text format     Abstract available


  62. PAN P, Oshima K, Huang YW, Agle KA, et al
    Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors.
    Int J Cancer. 2018 Mar 9. doi: 10.1002/ijc.31366.
    PubMed     Text format     Abstract available


    February 2018
  63. MARQUEZ J, Fernandez-Pineiro I, Arauzo-Bravo MJ, Poschmann G, et al
    Targeting liver sinusoidal endothelial cells with miR-20a-loaded nanoparticles reduces murine colon cancer metastasis to the liver.
    Int J Cancer. 2018 Feb 28. doi: 10.1002/ijc.31343.
    PubMed     Text format     Abstract available


  64. KABAT GC, Kim MY, Stefanick M, Ho GYF, et al
    Metabolic obesity phenotypes and risk of colorectal cancer in postmenopausal women.
    Int J Cancer. 2018 Feb 27. doi: 10.1002/ijc.31345.
    PubMed     Text format     Abstract available


  65. SHU X, Xiang YB, Rothman N, Yu D, et al
    Prospective study of blood metabolites associated with colorectal cancer risk.
    Int J Cancer. 2018 Feb 26. doi: 10.1002/ijc.31341.
    PubMed     Text format     Abstract available


  66. WU S, Meng Q, Zhang C, Sun H, et al
    DR4 mediates the progression, invasion, metastasis and survival of colorectal cancer through the Sp1/NF1 switch axis on genomic locus.
    Int J Cancer. 2018 Feb 15. doi: 10.1002/ijc.31318.
    PubMed     Text format     Abstract available


  67. KASHINO I, Akter S, Mizoue T, Sawada N, et al
    Coffee drinking and colorectal cancer and its subsites: A pooled analysis of 8 cohort studies in Japan.
    Int J Cancer. 2018 Feb 15. doi: 10.1002/ijc.31320.
    PubMed     Text format     Abstract available


  68. KOREHISA S, Oki E, Iimori M, Nakaji Y, et al
    Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
    Int J Cancer. 2018;142:822-832.
    PubMed     Text format     Abstract available


  69. LEW JB, James D, St John B, Macrae FA, et al
    Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31314.
    PubMed     Text format     Abstract available


  70. AMSHOFF Y, Maskarinec G, Shvetsov YB, Raquinio PH, et al
    Type 2 Diabetes and Colorectal Cancer Survival: The Multiethnic Cohort.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31311.
    PubMed     Text format     Abstract available


  71. SCHULLEHNER J, Hansen B, Thygesen M, Pedersen CB, et al
    Nitrate in drinking water and colorectal cancer risk: A nationwide population-based cohort study.
    Int J Cancer. 2018 Feb 13. doi: 10.1002/ijc.31306.
    PubMed     Text format     Abstract available


  72. FRANSGAARD T, Thygesen LC, Gogenur I
    Association between metformin use after surgery for colorectal cancer and oncological outcomes: A nationwide register-based study.
    Int J Cancer. 2018 Feb 13. doi: 10.1002/ijc.31305.
    PubMed     Text format     Abstract available


    January 2018
  73. O'BRIEN SJ, Carter JV, Burton JF, Oxford BG, et al
    The role of the miR-200 Family in Epithelial-Mesenchymal Transition in Colorectal Cancer: A Systematic Review.
    Int J Cancer. 2018 Jan 31. doi: 10.1002/ijc.31282.
    PubMed     Text format     Abstract available


  74. ISHIKAWA T, Okayama T, Sakamoto N, Ideno M, et al
    Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer.
    Int J Cancer. 2018 Jan 31. doi: 10.1002/ijc.31285.
    PubMed     Text format     Abstract available


  75. BUTT J, Jenab M, Willhauck-Fleckenstein M, Michel A, et al
    Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancer.
    Int J Cancer. 2018 Jan 29. doi: 10.1002/ijc.31283.
    PubMed     Text format     Abstract available


  76. MA H, Wu Z, Peng J, Li Y, et al
    Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximab.
    Int J Cancer. 2018 Jan 24. doi: 10.1002/ijc.31274.
    PubMed     Text format     Abstract available


  77. SETTE G, Salvati V, Giordani I, Pillozzi E, et al
    Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells.
    Int J Cancer. 2018 Jan 17. doi: 10.1002/ijc.31260.
    PubMed     Text format     Abstract available


  78. VAN SEBILLE YZA, Gibson RJ, Wardill HR, Ball IA, et al
    Dacomitinib-induced diarrhea: Targeting chloride secretion with crofelemer.
    Int J Cancer. 2018;142:369-380.
    PubMed     Text format     Abstract available


  79. BASU P, Ponti A, Anttila A, Ronco G, et al
    Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.
    Int J Cancer. 2018;142:44-56.
    PubMed     Text format     Abstract available


    December 2017
  80. GIES A, Bhardwaj M, Stock C, Schrotz-King P, et al
    Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31233.
    PubMed     Text format     Abstract available


  81. LIU W, Wang S, Sun Q, Yang Z, et al
    DCLK1 Promotes Epithelial-Mesenchymal Transition via the PI3K/Akt/NF-kappaB Pathway in Colorectal Cancer.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31232.
    PubMed     Text format     Abstract available


  82. JI J, Sundquist J, Sundquist K
    Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population-based study in Sweden.
    Int J Cancer. 2017 Dec 22. doi: 10.1002/ijc.31228.
    PubMed     Text format     Abstract available


  83. FENG HC, Lin JY, Hsu SH, Lan WY, et al
    Low folate metabolic stress reprograms DNA methylation-activated sonic hedgehog signaling to mediate cancer stem cell-like signatures and invasive tumour stage-specific malignancy of human colorectal cancers.
    Int J Cancer. 2017;141:2537-2550.
    PubMed     Text format     Abstract available


  84. ZHOU R, Shao Z, Liu J, Zhan W, et al
    COPS5 and LASP1 Synergistically Interact to Down-regulate 14-3-3sigma Expression and Promote Colorectal Cancer Progression via Activating PI3K/AKT Pathway.
    Int J Cancer. 2017 Dec 11. doi: 10.1002/ijc.31206.
    PubMed     Text format     Abstract available


  85. SCHWINGSHACKL L, Schwedhelm C, Hoffmann G, Knuppel S, et al
    Food groups and risk of colorectal cancer.
    Int J Cancer. 2017 Dec 6. doi: 10.1002/ijc.31198.
    PubMed     Text format     Abstract available


  86. RAY AL, Berggren KL, Restrepo Cruz S, Gan GN, et al
    Inhibition of MK2 suppresses IL-1beta, IL-6, and TNF-alpha dependent colorectal cancer growth.
    Int J Cancer. 2017 Dec 2. doi: 10.1002/ijc.31191.
    PubMed     Text format     Abstract available


    November 2017
  87. BABAEI M, Balavarca Y, Jansen L, Lemmens V, et al
    Administration of Adjuvant Chemotherapy for Stage II-III Colon Cancer Patients: A European Population-based Study.
    Int J Cancer. 2017 Nov 21. doi: 10.1002/ijc.31168.
    PubMed     Text format     Abstract available


  88. YAMAUCHI M, Urabe Y, Ono A, Miki D, et al
    Serial profiling of circulating tumor DNA for optimization of anti-VEGF chemotherapy in metastatic colorectal cancer patients.
    Int J Cancer. 2017 Nov 14. doi: 10.1002/ijc.31154.
    PubMed     Text format     Abstract available


  89. DI J, Yang H, Jiang B, Wang Z, et al
    Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.
    Int J Cancer. 2017 Nov 6. doi: 10.1002/ijc.31140.
    PubMed     Text format     Abstract available


    October 2017
  90. ZHANG QL, Zhao LG, Li HL, Gao J, et al
    The joint effects of major lifestyle factors on colorectal cancer risk among Chinese men: A prospective cohort study.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31126.
    PubMed     Text format     Abstract available


  91. HOLCH JW, Ricard I, Stintzing S, Fischer von Weikersthal L, et al
    Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31114.
    PubMed     Text format     Abstract available


  92. NIELL N, Larriba MJ, Ferrer-Mayorga G, Sanchez-Perez I, et al
    The human PKP2/Plakophilin-2 gene is induced by Wnt/beta-catenin in normal and colon cancer-associated fibroblasts.
    Int J Cancer. 2017 Oct 16. doi: 10.1002/ijc.31104.
    PubMed     Text format     Abstract available


  93. HIDAYAT K, Yang CM, Shi BM
    Body Fatness at an Early Age and Risk of Colorectal Cancer.
    Int J Cancer. 2017 Oct 12. doi: 10.1002/ijc.31100.
    PubMed     Text format     Abstract available


  94. PAN R, Zhu M, Yu C, Lv J, et al
    Cancer incidence and mortality: A cohort study in China, 2008-2013.
    Int J Cancer. 2017;141:1315-1323.
    PubMed     Text format     Abstract available


  95. VARGAS-PARRA GM, Gonzalez-Acosta M, Thompson BA, Gomez C, et al
    Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
    Int J Cancer. 2017;141:1365-1380.
    PubMed     Text format     Abstract available


    September 2017
  96. TANSKANEN T, van den Berg L, Valimaki N, Aavikko M, et al
    Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci.
    Int J Cancer. 2017 Sep 28. doi: 10.1002/ijc.31076.
    PubMed     Text format     Abstract available


  97. POTHOULAKIS C, Torre-Rojas M, Duran-Padilla MA, Gevorkian J, et al
    CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.
    Int J Cancer. 2017 Sep 20. doi: 10.1002/ijc.31064.
    PubMed     Text format     Abstract available


  98. WANG W, Xiao X, Chen X, Huo Y, et al
    Tumor-suppressive miR-145 co-repressed by TCF4-beta-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer.
    Int J Cancer. 2017 Sep 16. doi: 10.1002/ijc.31056.
    PubMed     Text format     Abstract available


  99. JAYASEKARA H, English DR, Haydon A, Hodge AM, et al
    Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype.
    Int J Cancer. 2017 Sep 16. doi: 10.1002/ijc.31049.
    PubMed     Text format     Abstract available


  100. MA B, Gao P, Wang H, Xu Q, et al
    What has preoperative radio(chemo)therapy brought to localized rectal cancer patients in terms of perioperative and long-term outcomes over the past decades? A systematic review and meta-analysis based on 41,121 patients.
    Int J Cancer. 2017;141:1052-1065.
    PubMed     Text format     Abstract available


  101. VEDELD HM, Merok M, Jeanmougin M, Danielsen SA, et al
    CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.
    Int J Cancer. 2017;141:967-976.
    PubMed     Text format     Abstract available


    July 2017
  102. SCHIRRIPA M, Zhang W, Heinemann V, Cao S, et al
    Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial.
    Int J Cancer. 2017;141:383-392.
    PubMed     Text format     Abstract available


  103. GU F, Zhang H, Hyland PL, Berndt S, et al
    Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.
    Int J Cancer. 2017 Jul 12. doi: 10.1002/ijc.30883.
    PubMed     Text format     Abstract available


  104. CABEL L, Bidard FC, Servois V, Cacheux W, et al
    HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30863.
    PubMed     Text format     Abstract available


    June 2017
  105. VAN SEBILLE YZA, Gibson RJ, Wardill HR, Secombe KR, et al
    Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats.
    Int J Cancer. 2017;140:2820-2829.
    PubMed     Text format     Abstract available


    April 2017
  106. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
    Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: